National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

amrubicin hydrochloride
The hydrochloride salt of a third-generation synthetic 9-amino-anthracycline with antineoplastic activity. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II, resulting in inhibition of DNA replication, and RNA and protein synthesis, followed by cell growth inhibition and cell death. This agent has demonstrated a higher level of anti-tumor activity than conventional anthracycline drugs without exhibiting any indication of the cumulative cardiac toxicity common to this class of compounds. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Amirubicin Hydrochloride
Foreign brand name:Calsed
Abbreviation:AMR
Chemical structure names:
  • (+)-(7S,9S)-9-acetyl-9-amino-7-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]- 6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
  • 5,12-naphthacenedione, 9-acetyl-9-amino-7-[(2-deoxy-β-D-erythro- pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, (7S,9S)-



Previous:Amoxil, amphotericin B deoxycholate, ampicillin sodium/sulbactam sodium, Ampligen, Amplimexon
Next:Amsa P-D, amsacrine, anakinra, anamorelin hydrochloride, anastrozole

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov